Key Highlights
- Arm unveiled the AGI CPU, marking its first internally developed chip designed for agentic AI data center applications
- Meta served as the primary development partner and initial customer for the new processor
- The company forecasts approximately $15 billion in annual revenue from this chip within a five-year timeframe
- Raymond James elevated ARM from Market Perform to Outperform, setting a $166 price target
- Updated guidance points to $3 per share earnings in FY2028, escalating to $9 per share by FY2031
Arm Holdings executed a significant strategic pivot on Wednesday, unveiling the AGI CPU — its first proprietary chip design — engineered specifically for agentic AI applications in data center environments.
Arm Holdings plc American Depositary Shares, ARM
The announcement represents a fundamental shift in Arm’s business approach. Historically, the company generated revenue by licensing chip architectures to manufacturers like Nvidia and Qualcomm, then collecting royalties on each unit sold. This new direction changes that equation.
While conventional processors target chatbot query processing, the AGI CPU addresses “agentic AI” — autonomous systems that execute tasks on behalf of users with minimal human intervention. These workloads require substantially more processing capability, which Arm positions its chip to deliver efficiently.
The AGI CPU architecture incorporates Neoverse V3 cores and includes 96 lanes of PCIe Gen6 memory bandwidth combined with CXL 3 memory expansion capabilities. According to Arm, the chip provides double the performance of premium x86 CPUs when configured in rack deployments.
Meta signed on as the primary development collaborator and inaugural customer. The social media giant intends to implement the AGI CPU working in tandem with its proprietary MTIA accelerator.
CEO Rene Haas shared with Reuters that this data center processor alone could generate approximately $15 billion annually within five years. The company anticipates total revenue reaching $25 billion during that period.
Arm revised its earnings projections upward, now targeting $3 per share in FY2028, with expectations climbing to $9 per share by FY2031.
Analyst Response
Raymond James acted swiftly, elevating ARM from Market Perform to Outperform while establishing a $166 price target. Analyst Simon Leopold characterized the transition into chip manufacturing as a strategic direction he had advocated for since initiating coverage.
Leopold emphasized that this move would generate robust operating profit while creating an entirely new revenue stream, though he had previously questioned whether majority stakeholder SoftBank would approve such a direction.
HSBC maintains a Buy rating on ARM with a $205 price target, highlighting Arm’s opportunities in the AI server CPU segment. BofA continues with a Neutral stance while lifting its target to $140. Morgan Stanley holds an Overweight rating at $135.
InvestingPro data indicates 19 analysts have increased earnings projections for upcoming periods. The stock currently carries a P/E ratio of 178.5, which InvestingPro’s Fair Value analysis suggests exceeds fundamental valuations.
Broader Chip Sector Impact
The announcement created positive momentum across the semiconductor industry. Intel shares advanced 3.4% in premarket trading, while AMD gained over 1%.
Citigroup analysts observed that Arm “has not taken a baby step” — the company proceeded directly to comprehensive chip development. They identified the industry’s transition toward inference and agentic AI as the catalyst driving increased demand for CPU processing power.
Arm presently trades at 63x forward earnings projections, while AMD trades at 26.6x and Intel at 71.3x, based on LSEG data.
Arm’s upcoming “Arm Everywhere” event approaches, where the company plans to reveal further information regarding its independent merchant CPU roadmap.
